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SIMPSON, C. W., C. CUMMINS AND L. V. DICARA. Dopamine-B-hydroxylase activity in rat hypothalamus during the 
estrus cycle. PHARMAC. BIOCHEM. BEHAV. 3(4) 693-696, 1975. -- This experiment provides a direct test of our 
previous suggestion that estradiol regulates dopamine-B-hydroxylase (DBH) activity in hypothalamic loci. Anterior, 
medial and posterior hypothalamic slices from triplets of rats were taken during estrus and diestrus and assayed for 
DBH activity using the technique of Molinoff et al. [15]. DBH activity was measured in hypothalamic slices on three 
different occasions from three triplets during the estrous phase of the cycle and also from separate triplets during the 
diestrous stage of the cycle. Results showed a significant increase in DBH activity during the estrous phase of the cycle. 
Increased activity did not appear to be anatomically localized within the tissue slices. Explanation of the results has 
been discussed in terms of possible mechanisms of action. 
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RECENTLY we [18] have described behavioral evidence 
supporting the hypothesis of an interaction effect between 
estradiol and dopamine B hydroxylase (DBH) activity at 
hypothalamic loci. Molinoff et al. [16] have measured 
regional levels of DBH in rat brain and report very high 
concentrations in the hypothalamus. Although DBH activ- 
ity has not been measured under different conditions of 
estradiol influence, end product concentrations of nor- 
epinephrine (1-NE) have been reported. 
Donoso and Stefano [8] first reported significant 
increases in 1-NE and reciprocal decreases in dopamine in 
the anterior hypothalamus of ovariectomized female rats. 
Daily doses of estradiol plus progesterone reversed the 1-NE 
and dopamine levels in anterior hypothalamus of these 
animals to those reported in intact rats. This group [19] 
has also assayed anterior hypothalamic 1-NE during the 
estrus cycle. Norepinephrine levels are lowest at estrus and 
increase during diestrus. Donoso and Cukier [6] manipu- 
lated endogenous estradiol levels by a number of proce- 
dures and reported the subsequent effects on anterior 
hypothalamic norepinephrine levels. All groups charac- 
terized by high endogenous levels of estradiol showed a 
significant decrease in anterior hypothalamic 1-NE com- 
pared to appropriate control groups. Ovariectomy signifi- 
cantly increased 1-NE levels in anterior hypothalamus for 
all groups. Finally, a number of laboratories [1 ,2 ,  7] have 
reported significant increases in 1-NE metabolism in 
anterior hypothalamus following ovariectomy. 
This study tested the hypothesis that DBH activity is 
significantly altered in rat anterior hypothalamus during the 




Eighteen female Sprague-Dawley rats purchased from 
Spartan Animals served for this experiment. Rats were 
between 90 and 100 days old when sacrificed. Only rats 
showing regular 4 or 5 days estrous cycle were used for this 
experiment. Hormone condition of the animals was deter- 
mined on the day of  the experiment by vaginal smears 
examined microscopically. The estrous smear was charac- 
terized by a large number of nucleated epithelial cells and 
the absence of leucocytes. Diestrous smears featured an 
absence of  epithelial cells and a large number of leucocytes. 
Triplets of animals in the same hormone condition were 
utilized for the assay. Six separate assays on 6 triplets were 
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conducted, separated by approximately one week each. 
Three triplets were assayed in the diestrous condition and 
three triplets from the estrous stage of the cycle. All 
animals were overdosed with pentobarbital sodium and 
brain slices of approximately equal weight were taken from 
anterior, middle and posterior diencephalon of each animal. 
Histology 
One rat of similar weight was overdosed with pento- 
barbital sodium and perfused with formalin through the 
ascending aorta. Hypothalamic slices of similar weight were 
taken through anterior, middle and posterior hypo- 
thalamus. Sections were cut at 8/~ and stained with crysel 
violet to determine anterior and posterior boundaries for 
the hypothalamic slices. 
Assay Procedures 
Methods. Assay of Dopamine-B-Hydroxylase in this 
paper was based on the method of Molinoff et al. [17]. 
Briefly, this technique utilized bovine adrenal enzyme, 
Phenylethanolamine-N-methyl transferase, and an artificial 
substratum phenylethylamine. DBH hydroxylates this 
compound to phenylethanolamine at the Beta position. 
PNMT converst phenylethanolamine to its N-methyl 
derivative, N-methyl-phenylethanolamine. When PNMT is 
used in excess in this system, DBH becomes rate limiting 
and the N-methylated product is directly proportional to 
DBH activity. 
Isolation o f  PNMT. PNMT was isolated from beef 
adrenal glands according to Molinoff et al. [17]. The 
adrenal glands were obtained fresh from the slaughterhouse. 
Glands were cleaned of extraneous fat, and homogenized in 
a Waring Blender in 2 volumes of 1.15 percent KCI. The 
homogenate was centrifuged at 100,000 X G for 40 rain at 
4°C,  and the red turbid supernatant was frozen at - 7 0  
degrees until used in the further purification steps. 
Ammonium sulfate was added to a thawed batch of high 
speed supernatant to a concentration of 30 percent (176 
g/1). The pellet was collected by centrifugation at 10,000 X 
G for 10 min. The pellet was discarded, and the supernatant 
was retained. A further 126 g/1 of ammonium sulfate was 
added to the supernatant, bringing the final concentration 
of ammonium sulfate to 50 percent. 
The pellet was collected as before, and the supernatant 
discarded. The pellet was suspended in a minimal volume of 
buffer, consisting of 0.001 M Tris, pH 7.4 and was dialyzed 
overnight against 500 volumes of 0.01 M Tris pH 7.4. Forty 
volumes of this dialysate were passed over a Sephadex 
G-200 column (3 X 100 cm.). The samples were eluted with 
0.05 M Tris pH 7.4, and 10 ml aliquots were collected. 
PNMT activity was assayed according to Molinoff et al. 
[17]. 100 /~1 aliquots of each of the 10 ml eluates collected 
from the column were mixed with 25 /4 of 0.0146 M 
Phenylethanolamine (2 mg/ml) 1 ~tl of SAMe (NEN, 
specific activity 58 m Ci mmole of Tris buffer, pH 8.6, a 
total volume of 200/4.  The reaction was terminated by the 
addition of 0.5 ml of 0.5 M Na Borate buffer, pH 10.0. The 
N-methylated phenylethanolamine was extracted into 6 ml 
toluene-3% isoamyl alcohol, and 3 ml of the latter was 
counted in a Beckman LS-250 liquid scintillation counter. 
D B H  Assay. For each assay, female rats, 2 0 0 - 2 5 0  g, 
were smeared to determine estrous state. Rats were lightly 
etherized, decapitated, and the brains removed and placed 
in ice cold saline until used (usually within 3 hr). 
Tissue blocks were removed and homogenized in 40 
volumes of 0.005 M Tris, pH 7.5, containing 0.1% Triton X 
100. The samples were spun at 10,000 X G for 10 min, and 
the supernatant was used for the assay. 
The solution for the assay of DBH consisted of 25 
volumes of 0.5 M Na fumarate, pH 6.0, 5 volumes of 0.006 
M pargyline, 5 volumes of catalase (@ 5.5 × 104 units/ml), 
5 volumes of 1.0 M Tris buffer, pH 6.0, 5 volumes of 0.03 
M phenylethylamine, and 5 volumes of CuSO4, 150 mM. 
The reaction was begun by the addition of 100/J1 of the 
DBH assay medium to 200 /21 of rat brain supernatant. The 
initia! phase of the assay was allowed to proceed for 80 
minutes, and at the end of this time 200/21 of a mixture 
containing 5 121 of SAMe, 25 ~1 of PNMT, and 175/4 of Tris 
buffer at pH 8.6 was added. According to Molinoff et al., 
the change in pH of the reaction mixture, from pH 6.0 to 
pH 8.6 inhibits DBH activity by 95% [17]. The PNMT 
portion of the assay was allowed to proceed for 20 minutes. 
At the end of this time, the reaction was stopped by the 
addition of 0.5 ml of 0.5 M Na Borate buffer, at pH 10.0. 
The entire enzymatic assay was conducted at 37°C. 
The sample tubes were layered with 6 ml of to luene-3  
percent isoamyl alcohol, and vortexed virogously. The 
phases were allowed to separate, and 3 ml of the upper 
phase were removed, placed in scintillation vials containing 
10 ml of 1 g dimethyl POPOP, 4.0 g PPO per liter of 
toluene. 
Blanks employed in this assay were tubes containing 
tissue heated to 100°C for 5 min. Internal standards were 
also run with each series of experimental tubes. Internal 
standards consisted of experimental tubes to which were 
added 10 /21 of 0.02 mg/ml phenylethanolamine just prior 
to the addition of SAMe and PNMT. Percent of PNMT 
inhibition could be expressed as the ratio of the observed 
counts per minute to the expected counts per minute. The 
use of internal standards permitted the calculation of the 
absolute activity of DBH, and allowed correction for 
inhibition of PNMT by experimental samples (Molinoff et 
al. [171). 
RESULTS 
Table 1 shows the results of the DBH assay. Activity 
within each of the hypothalamic brain slices is given for 
both estrous and diestrous hormone conditions for each of 
the 6 triplets used. It is important to recall that in this assay 
the formation of product is directly proportional to the 
amount of enzyme present when phenylethylamine is used 
as substrate. DBH activity differences were compared by a 
2 × 3 split plot analysis of variance. The Hormone 
condition main effect was significant, F(1,4) = 12.09, 
p<0.05. The location variable was not significantly differ- 
ent, F(2,8) = 2.16, p>0.05, nor was the location X 
hormone interaction, F(2,8) = 2.80, p>0.05. 
The anatomical data are summarized below. Anterior 
slices begin in the lateral septal area slightly anterior to the 
optic chiasm and extend through the anterior hypo- 
thalamus to the initial development of the hippocampus. 
The area used for the assay lies between K6nig and Klippel 
Plates 16 b and 30 b. The anterior boundary of the medial 
hypothalamic slices was the level of the ventro-medial and 
dorsomedial hypothalamus. Posteriorly, the medial section 
terminated at the level of the prerubal fields of Forel, 
dorsal pre-mammilary nucleus and arcuate area. Medial 
sections were taken between Plates 32 b to 40 b from the 
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TABLE 1 
THE ABSOLUTE LEVEL OF DBH ACTIVITY EXPRESSED AS 
nm PRODUCED/HR/gm WEIGHT FOR ANTERIOR, MEDIAL 
AND POSTERIOR HYPOTHALAMIC TISSUE SLICES TAKEN 
FROM RATS DURING ESTROUS OR DIESTROUS PHASES OF 
THE RAT ESTROUS CYCLE 
Hormone Condition Section 
Activity 





































rat atlas. The most posterior hypothalamic sections ex- 
tended from mammillary bodies to the supramammillary 
decussation. Posterior hypothalamic slices used or the 
DBH assay were taken from the area described between 
Plates 42 b and 44 b of the KSnig and Klippel atlas. 
DISCUSSION 
The significant increase in DBH activity measured in our 
assay system demonstrates that estradiol effects enzyme 
levels at different stages of the estrous cycle. 
As pointed out in the results section, DBH activity for 
different hypothalamic tissue slices both within each assay 
and between assay conditions were very consistent for 
estrous and diestrous hormone conditions. This lack of 
anatomical specificity is not too surprising, when it is 
recalled that the slices were not microdissected from 
different areas, but were taken as a continuous slice of 
approximately 2 - 3  ram. In addition, all slices contained 
varying proportions of both estrogen sensitive receptors as 
localized by Stumpf [20], and receptor areas innervated by 
both dorsal and ventral noradrenergic fiber bundles as 
discussed by Ungerstedt [21 ]. While more microdissection 
experiments are necessary to assess regional differences in 
activity, our data tend to support a more general effect of 
estrogen on DBH activity, wherever DBH activity is 
localized. 
Norepinephrine levels in the brain are undoubtedly 
controlled by a complex array of conditions. DBH plays a 
significant role in this scheme of controls, in that it 
catalizes the rate limiting step from dopa to norepinephrine 
[31. 
There are at least two primary ways in which DBH 
activity can be regulated; (1) allosteric or feedback control, 
or (2) de novo synthesis. 
DBH does not seem to be regulated directly by NE 
concentrations in an in vitro system [ 11 ], and this is most 
probably true also in vivo, inasmuch as physical data do not 
suggest allosteric binding sites on purified preparations 
of enzyme [10]. 
Both estrogen and neuronal electric activity can increase 
enzyme activity and the de novo  synthesis of proteins [4, 5, 
10, 11, 17]. Jensen [13] has shown that the synthesis of a 
wide variety of proteins can be stimulated by estrogen 
treatment of uterine tissue. Since estrogen receptor sites 
have been shown by Stumpf in the hypothalamus [20], it is 
possible that we are demonstrating the direct synthesis of 
DBH in response to high levels of estrogen. Tyrosine 
hydroxylase, an enzyme, is thought to catalize the rate 
limiting step in the biosynthesis of NE. Beattie and his 
colleagues [4] have recently measured this enzyme in the 
hypothalamus of rats after ovariectomy and under condi- 
tions of estrogen replacement therapy. Although tyrosine 
hydroxylase in rat hypothalamus increased after ovariec- 
tomy, replacement therapy (1 rag/day estradiol, for 7 days) 
further increased tyrosine hydroxylase by 30 percent. 
The possibility exists, on the other hand, that the 
increase in DBH activity could be due to de novo  synthesis 
in response to an increase in nerve cell activity, induced by 
estrogen. Zolovic et  al. [22] reported that a major NE and 
dopamine catabolizing enzyme monoamine oxidase in- 
creased markedly during estrous. These authors suggested 
that nerve cell activity was the cause for this increase. 
Molinoff [ 16] noted that after reserpine depletion of NE in 
the rat stellate ganglion preparation, DBH increased dra- 
matically. They interpreted this finding to mean that as NE 
is depleted, there is an increase in DBH activity, due to de 
novo  synthesis. 
Along these same lines, it is interesting to note that 
estrogen incubated in a synaptosomal preparation decreased 
re-uptake of NE [12]. If this system parallels the in vivo 
effect of estrogen, a NE depletion would occur. This, in 
turn, would increase the activities of the intermediate 
enzymes, and at the same time tend to deplete the vesicular 
bound NE. Thus, the mechanisms of de novo  synthesis and 
membrane re-uptake inhibition could account for the data 
presented here and elsewhere [6,16], which shows an 
increased DBH activity, and a substantially low NE level. 
It is impossible to determine from these data the exact 
mechanism mediating the increase in DBH demonstrated in 
this experiment. However, both mechanisms are funda- 
mentally consistent with the original hypothesis that 
estrogen profoundly effects the DBH activity in the rat 
hypothalamus during the estrous cycle. 
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